This study investigates the safety and tolerability of an investigational medication in participants with locally advanced or metastatic solid tumors.
The study focuses on evaluating how safe and tolerable the investigational medication is when given to participants. It looks at how the body handles the medication and investigates finding a suitable dose for future research.
- Who can participate: Adults aged 18 and older with advanced or metastatic solid tumors that have no effective therapy available may participate. Participants should have adequate organ function and a life expectancy of at least 3 months.
- Study details: Participants will receive the investigational medication to evaluate its effects.